Incidence and outcome of Kawasaki disease in Malta

V Grech1

  • 1Department of Paediatrics, St. Luke's Hospital, Guardamangia, Malta. vgrech@mail.link.net.mt

Insights

Kawasaki disease (KD) incidence in Malta is low compared to Asian populations, with no reported coronary arteritis complications. Increased medical awareness has reduced diagnosis delays for this childhood illness.

Area of Science:

  • Pediatrics
  • Rheumatology
  • Epidemiology

Background:

  • Kawasaki disease (KD) is a critical pediatric illness causing arteritis, potentially leading to severe cardiovascular complications.
  • The unknown etiology of KD necessitates understanding its geographic and demographic variations.
  • Coronary artery involvement in KD poses significant risks, including aneurysm formation and myocardial infarction.

Purpose of the Study:

  • To determine the incidence of Kawasaki disease in Malta.
  • To compare KD incidence and morbidity in Malta with international data.
  • To assess trends in diagnostic delay for KD in Malta.

Main Methods:

  • Retrospective analysis of KD cases in Malta over a defined period.
  • Comparison of Maltese KD incidence rates with published data from various global populations.
  • Evaluation of diagnostic timelines and clinical outcomes, including cardiovascular complications.

Main Results:

  • The incidence of KD in Malta was found to be 3.2 per 100,000 population under 5 years of age.
  • Maltese incidence rates are comparable to non-Asiatic communities and significantly lower than Asiatic populations.
  • No cases of coronary arteritis or other severe complications were observed in the Maltese cohort.

Conclusions:

  • Kawasaki disease incidence in Malta is relatively low, particularly concerning cardiovascular complications.
  • Increased awareness within the medical community has led to a significant reduction in diagnostic delays.
  • Further research into KD's etiology and prevention remains crucial for global public health.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...